RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Anil Shanker to Antibodies, Monoclonal

This is a "connection" page, showing publications Anil Shanker has written about Antibodies, Monoclonal.
Connection Strength

1.373
  1. Renrick AN, Dunbar ZT, Shanker A. Update?on the current revolution in cancer immunotherapy. Immunotherapy. 2019 01; 11(1):15-20.
    View in: PubMed
    Score: 0.605
  2. Shanker A, Dikov MM, Carbone DP. Promise of Immunotherapy in Lung Cancer. Prog Tumor Res. 2015; 42:95-109.
    View in: PubMed
    Score: 0.480
  3. Shanker A, Brooks AD, Tristan CA, Wine JW, Elliott PJ, Yagita H, Takeda K, Smyth MJ, Murphy WJ, Sayers TJ. Treating metastatic solid tumors with bortezomib and a tumor necrosis factor-related apoptosis-inducing ligand receptor agonist antibody. J Natl Cancer Inst. 2008 May 07; 100(9):649-62.
    View in: PubMed
    Score: 0.289
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support